Extreme hypo fractionation with biodegradable rectal spacer insertion
Topic Status Complete
Extreme hypo fractionation combined with biodegradable rectal spacer insertion for prostate cancer radiotherapy.
Specialities: Cancer; Genitourinary system
Summary
This report was prepared by Health Technology Wales on behalf of the Bevan Commission. It summarises the existing evidence on the technology of interest to support a Bevan health technology exemplar application.
Topic Exploration Report
TER133 11.2019
Health Technology Wales Partners
